InvestorsHub Logo
Followers 5
Posts 859
Boards Moderated 0
Alias Born 09/28/2012

Re: None

Tuesday, 10/31/2017 10:11:20 AM

Tuesday, October 31, 2017 10:11:20 AM

Post# of 8553
"Halozyme will receive a $15 million milestone payment from Janssen following dosing of the third patient in a Phase 3 trial."

https://ih.advfn.com/p.php?pid=nmona&article=75977191
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News